Role of chemotherapy before allogeneic stem cell transplantation (allo-SCT) from an HLA-identical sibling donor for myelodysplastic syndrome (MDS).

被引：0
|
作者：
Nakai, K
Kanda, Y
Fukuhara, S
Sakamaki, H
Okamoto, S
Kodera, Y
Tanosaki, R
Takahashi, S
Matsushima, T
Atsuta, Y
Hamajima, N
Kasai, M
Kato, S
机构：
[1] Kansai Med Univ, Dept Internal Med 1, Osaka, Japan
[2] Tokyo Univ Hosp, Dept Cell Therapy & Transplantat Med, Tokyo 113, Japan
[3] Tokyo Metropolitan Komagome Hosp, Div Hematol, Tokyo, Japan
[4] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan
[5] Nagoya First Hosp, Japanese Red Cross, Dept Internal Med, Nagoya, Aichi, Japan
[6] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Unit, Tokyo 104, Japan
[7] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan
[8] Gunma Univ, Grad Sch med, Dept Med & Clin Sci, Gunma, Japan
[9] Nagoya Univ, Grad Sch Med, Dept Prevent Med Biostat & Med Decis Making, Nagoya, Aichi, Japan
[10] Sapporo Hokuyu Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan
[11] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 25911, Japan
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5126
引用
收藏
页码：365B / 365B
页数：1
相关论文
共 50 条
  • [31] Donor and Recipient Genotypes for Interleukin 1 Gene Single Nucleotide Polymorphisms (SNPs) Allow Anticipation of Acute Graft Versus Host Disease after HLA-Identical Allogeneic Stem Cell Transplantation (allo-SCT)
    Buces, Elena
    Martinez-Laperche, Carolina
    Gonzalez-Rivera, Milagros
    Bosch-Vizcaya, Anna
    Martin-Antonio, Beatriz
    Guillem, Vicent
    Nieto, Jose B.
    Gonzalez, Marcos
    De La Camara, Rafael
    Brunet, Salut
    Jimenez-Velasco, Antonio
    Espigado, Ildefonso
    Vallejo, Carlos
    Sampol, Antonia
    Maria Bellon, Jose
    Serrano, David
    Kwon, Mi
    Gayoso, Jorge
    Pascual, Balsalobre
    Urbano-Izpizua, Alvaro
    Solano, Carlos
    Gallardo, David
    Diez Martin, Jose Luis
    Buno, Ismael
    BLOOD, 2014, 124 (21)
  • [32] Chemotherapy followed by donor lymphocyte infusions (DLI) for treatment of acute leukemia recurrence after allogeneic stem cell transplantation (allo-SCT).
    Taylor, K
    Finiewicz, KJ
    Moreb, JS
    Reddy, V
    Khan, SA
    Boyette, R
    Shroff, S
    Roque, D
    Manion, K
    Wingard, JR
    BLOOD, 2000, 96 (11) : 350B - 350B
  • [33] Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies
    Hamaki, T
    Kami, M
    Kim, SW
    Onishi, Y
    Kishi, Y
    Murashige, N
    Hori, A
    Kojima, R
    Sakiyama, M
    Imataki, O
    Heike, Y
    Tanosaki, R
    Masuo, S
    Miyakoshi, S
    Taniguchi, S
    Tobinai, K
    Takaue, Y
    BONE MARROW TRANSPLANTATION, 2004, 33 (09) : 891 - 900
  • [34] Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies
    T Hamaki
    M Kami
    S-W Kim
    Y Onishi
    Y Kishi
    N Murashige
    A Hori
    R Kojima
    M Sakiyama
    O Imataki
    Y Heike
    R Tanosaki
    S Masuo
    S Miyakoshi
    S Taniguchi
    K Tobinai
    Y Takaue
    Bone Marrow Transplantation, 2004, 33 : 891 - 900
  • [35] Fludarabine-busulphan reduced intensity conditioning (RIC) identical sibling allogeneic stem cell transplantation (Allo-SCT) in high risk acute myeloid leukemia and myelodisplastic syndrome
    Valcarcel, D.
    Martino, R.
    Martin, J.
    Ferra, C.
    Sampol, A.
    Nieto, J. B.
    Carrera, D.
    Pinana, J. L.
    Caballero, D.
    Ribera, J. M.
    Besalduch, J.
    Moraleda, J. M.
    Bernal, M. T.
    San Miguel, J.
    Sierra, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 134 - 135
  • [36] Selinexor Maintenance Is Feasible and Tolerable after Allogeneic Stem Cell Transplant (allo-SCT) for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Liu, Hongtao
    Artz, Andrew
    Larson, Richard A.
    Kosuri, Satyajit
    Stock, Wendy
    Bishop, Michael R.
    BLOOD, 2017, 130
  • [37] ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHILDREN FROM OTHER THAN HLA-IDENTICAL SIBLING DONOR
    LOCATELLI, F
    BONGIORNO, M
    ZECCA, M
    GIANI, S
    GIORGIANI, G
    GUAGNINI, R
    MORANDI, P
    PORTA, F
    NESPOLI, L
    BURGIO, GR
    SEVERI, F
    BONE MARROW TRANSPLANTATION, 1991, 7 : 124 - 127
  • [38] Allogeneic stem cell transplantation (SCT) from HLA-identical siblings in patients with myelodysplasia or secondary acute myeloid leukemia
    Runde, V
    de Witte, T
    van Biezen, A
    Hermans, J
    Arnold, R
    Locatelli, F
    Gratwohl, A
    Apperley, J
    BONE MARROW TRANSPLANTATION, 1999, 23 : S153 - S153
  • [39] Profile of infectious complications following allogeneic HLA-identical sibling transplantation (allo-SCT) with anti-T-lymphocyte globulin-based reduced intensity preparative regimen (RIC)
    Mohty, M
    Jacot, W
    Faucher, C
    Collet, L
    Zandotti, C
    Bilger, K
    Vey, N
    Blaise, D
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 69 - 69
  • [40] Allogeneic stem cell transplantation (allo-SCT) in adult acute lymphoblastic leukemia (ALL)
    Wu, S. J.
    Yao, M.
    Tang, J. L.
    Chen, Y. C.
    Cheng, A. L.
    Tien, H. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345